Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy

NCT04715646 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT04715646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04715646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy
Lead sponsor
UCB Biopharma SRL
Phase
Phase 3
Overall status
Recruiting
Start date
March 11, 2021
Completion date
July 8, 2030
Enrollment
70 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy